The latest scientific research results were presented at the world's top pediatric nutrition conference.
RecentlyBingoshowdownfreeChina's first multi-combinatorial study of infant formula using macro-genome sequencing technology has made a breakthrough. The study found that 9Bingoshowdownfree1 the ratio of probiotics (galactose oligosaccharides and fructose oligosaccharides) can accurately regulate the immune core beneficial bacteria dominated by Bifidobacterium and help to strengthen the intestinal immune barrier. The latest scientific findings brought by Neudicia received wide attention from experts and participants around the world at the 56th Annual meeting of the European Society of Pediatric Gastroenterology, Hepatology and Nutrition (ESPGHAN).
Relying on the metagenome sequencing technology, the local clinical trial "Kylin study" launched by Neudisia and a team of Chinese researchers accurately revealed the characteristics of intestinal flora development in Chinese babies during the key immune shaping period (0-24 months old) for the first time. In general, the intestinal tract contains thousands of species of bacteria, reaching trillions of levels, and cannot be isolated and understood by traditional biological methods. The metagenome sequencing technology makes a breakthrough in the application of a new generation of gene sequencing technology from the molecular biology level, enabling scientists to analyze the whole genome of intestinal microflora with high precision. For the first time, the developmental characteristics of intestinal microflora in Chinese infants from 0 to 24 months were more accurately described at the strain level, and it was verified that 9:1 combined with Yishengyuan could support the dominant growth of Bifidobacterium members. At the same time, it can effectively inhibit the growth of various conditional pathogenic bacteria and bring health benefits to the baby.
Newdicia showcases the latest scientific research results at ESPGHAN
"thanks to multi-group analysis capabilities such as macrogene sequencing, we can further explain how the more than 100 structures of probiotics at a particular 9:1 ratio deconstruct the function of breast milk oligosaccharides and accurately regulate the growth of immune-related bacteria such as Bifidobacterium," said Bernd Stahl, director of research and analysis science at Danone Newdigia and associate professor at Utrecht University in the Netherlands.
Neudigia is the first company in the world to confirm the structural characteristics of complex short and long chains of breast milk oligosaccharides. Using a specific 9:1 prebiotic combination corresponding to its characteristics, we conducted more than 40 clinical intervention studies and published more than 90 related scientific papers for different target groups in the early 1000 days of life. Not only that, this unique combination of probiotics has also been widely recognized by international organizations such as the European Union and the United States FDA. " Bernd Stahl said.
In addition, at the expert seminar held during ESPGHAN, the top pediatricians at home and abroad discussed the probiotics and symbiosis needed in the early stage of life, and reached and issued a consensus on science. Clinical studies have shown that 9:1 probiotics and Bifidobacterium brevis Mmur16V have synergistic immune effect. Short Bifidobacterium MMel 16V is a common short bifidobacterium in the intestinal tract of infants, which is easier to settle in the intestinal tract of infants and establish intestinal immune barrier. " Jan Knol, professor of early life intestinal microbiology at Wageningen University in the Netherlands and director of intestinal biology and microbiology research and development at Danenneudia Research Center, concluded.
Neudicia has 128 years of scientific research experience and is committed to the research and development of nutrition and intestinal immunity of infants and young children in early life. Its parent company, Danone, has nearly 5000 patents and applications, published more than 300 papers and conducted 45 clinical studies in the field of breast milk research.
Professor Yvan Vandenplas, former chairman of the ESPGHAN Gastroenterology Committee, said: "Neudicia is committed to scientific exploration and clinical application of early life nutrition, especially in the field of infant immunization. The academic cooperation between Nudicia and ESPGHAN has lasted for many years, which has promoted the development of pediatric nutrition and helped the healthy growth of infants and young children around the world, including China. "
It is understood that, as a widely verified and important scientific research achievement, 9:1 ratio probiotics has been used in many series of Aitamei products.
9:1 proportion of prebiotics has been used in many series of Aitamei products.
(disclaimer: the content of this article is an advertisement, the relevant material is provided by the advertiser, and the advertiser is responsible for the authenticity of this advertisement. The purpose of this website is to convey more information, it does not mean that this website agrees with its point of view and is responsible for its authenticity, please verify the relevant content yourself. The advertising content is for readers' reference only. )
